In cancer cells, STAT5 activation lead to the increased expression of downstream target genes (Bcl-xL, mcL-1, cyclinD1 /D2 and c-myc), which increased cell proliferation, cell survival, angiogenesis, and immune system evasion [17]. This evidence concerns the gene MYC and cancer.